Rita Ciaravino

Title: Rita Ciaravino: Innovator in Immunotherapy Treatment Prediction

Introduction

Rita Ciaravino is a prominent inventor based in Grosse Pointe Farms, MI (US). She has made significant contributions to the field of medical technology, particularly in the area of immunotherapy treatment prediction. With a total of two patents to her name, her work is paving the way for advancements in patient care and treatment planning.

Latest Patents

Rita's latest patents focus on predicting responses to immunotherapy treatment using deep learning analysis of imaging and clinical data. One of her methods involves training deep learning models with sets of training data from multiple patients to predict treatment responses that indicate a patient's survival rate based on changes in lesion volume. This innovative approach includes providing a single pre-treatment image of a target lesion to the trained models, which generate immunotherapy treatment responses. Another patent outlines a method that utilizes a pre-treatment image of a target subject to predict treatment responses, ultimately leading to a recommended treatment plan based on the predicted response score.

Career Highlights

Rita Ciaravino is currently associated with Onc.ai, Inc., where she applies her expertise in deep learning and medical imaging to enhance treatment outcomes for patients undergoing immunotherapy. Her work is instrumental in integrating advanced technology with clinical practices, thereby improving the accuracy of treatment predictions.

Collaborations

Rita collaborates with notable professionals in her field, including Petr Jordan and Salmaan Ahmed. These partnerships contribute to the innovative research and development efforts at Onc.ai, Inc.

Conclusion

Rita Ciaravino's contributions to the field of immunotherapy treatment prediction exemplify the intersection of technology and healthcare. Her innovative patents and collaborative efforts are set to make a lasting impact on patient treatment strategies.